Ann: Kazia paxalisib Phase II interim data, page-15

Yes that’s right O/S we treat the 65% that TMZ can’t treat and we get a way better result in OS and PFS than TMZ the current standard of care...

PFS TMZ 5.3 months - vs - PFS PAX 8.5 months

OS TMZ. 12.7 months - vs - OS PAX 17.7 months

... no matter how anyone tries to spin it these results are the facts of any consequence.

“ We believe that paxalisib is rapidly becoming one of the most promising drug candidates in the global pipeline for this very challenging disease and we will be working strenuously to make it available to patients as quickly and efficiently as possible. “

They should print t-shirts with that quote...